Purvii, a new multilevel marketing venture, launched in June 2023 with claims of medical-grade accuracy from a health-scanning smartphone app. The company, founded by Indiana-based couple Tony and Jenny Lusby, pairs this technology with nutritional supplements. Tony and Jenny Lusby, who have a history with multiple MLM operations, are leading Purvii.
Jenny Lusby lists herself as CEO and founder on LinkedIn, while Tony uses the same titles on Facebook. Purvii's website, however, lists a third individual, Derrick DeSilva, in its "about us" section without clarifying his role. The Lusbys previously achieved Black Diamond Elite status, a top distributor rank, with Zilis. They also promoted Monavie and FGXpress. Their reasons for leaving Zilis around late 2021 or early 2022, despite their high standing, remain undisclosed.
The core of Purvii's business model is the Purscan app. This application purportedly uses transdermal optical imaging (TOI) to analyze blood flow. Users point their phone's camera at their face, and the app shines light through the skin, capturing reflected light patterns. This data is then processed by an "Affective AI engine" on cloud servers.
Purvii asserts that Purscan can accurately measure heart rate, blood pressure, stress levels, BMI, and risks for diabetes, high cholesterol, and elevated blood glucose. Marketing materials prominently feature the phrase "medical grade accuracy," though the company does not elaborate on what this designation signifies.
Digging into the fine print on Purvii's e-commerce pages reveals a crucial disclaimer. Purscan is designated as a screening tool, not a diagnostic one. It explicitly states the app does not diagnose, treat, prevent, or cure any medical conditions and does not substitute professional medical advice from a doctor.
The Purscan app carries a monthly subscription fee of $39.95, which includes 60 scans. The data generated by these scans is then used to recommend specific Purvii supplements. This creates a closed loop where the app's non-diagnostic findings purportedly lead to supplement purchases designed to address the detected issues.
The Lusby's history in MLM suggests a strong understanding of distributor-based sales models. The effectiveness and scientific validity of Purvii's health claims, particularly those related to the Purscan app, will be subject to scrutiny. The company's assertion of "medical grade accuracy" for a facial scan application, independent of peer-reviewed medical validation, raises significant questions.